Genuity Capital Markets
http://www.genuitycm.com/Genuity Capital Markets is a financial services firm providing investment banking, institutional sales and trading, and equity research to its corporate clients. The firm uses a simple Buy, Hold and Sell rating system in its research analysis.
View Older Stories View More Recent Stories
-
Canaccord Genuity Upgrades Freeport-McMoRan (FCX) to Buy
-
Canaccord Genuity Reiterates a 'Buy' Quidel Corp. (QDEL); No Surprise Q4 Flu Was Light
-
Canaccord Genuity Reiterates a 'Buy' on Protalix BioTherapeutics (PLX); Predict Timely US Approval on PDUFA
-
Canaccord Genuity Reiterates a 'Buy' on Metalico (MEA); Trimming Q4 Estimates But Upping 2011 Outlook
-
UPDATE - Canaccord Genuity Downgrades Fuel Tech (FTEK) to Hold; Risk/Reward Balanced - For Now
-
Canaccord Genuity Reiterates a 'Buy' on DragonWave (DRWI); Beyond Clearwire; a Preview Into 2011 (fiscal 2012)
-
Canaccord Genuity Downgrades Fuel-Tech (FTEK) to Hold
-
Amarin Corp. (AMRN) Intends ADS Offering
-
Canaccord Genuity Maintains a 'Hold' on AngioDynamics (ANGO); Solid FQ2 Results Make Us Modestly More Positive
-
UPDATE - Canaccord Genuity Initiates Coverage on eBay (EBAY) with a Hold; eBay Losing Share; PayPal Leads
-
UPDATE - Canaccord Genuity Initiates Coverage on Yahoo! (YHOO) with a Hold; Bleeding Share
-
UPDATE - Canaccord Genuity initiates Coverage on Shutterfly (SFLY) with a Hold; Sizeable Market Opportunity
-
UPDATE - Canaccord Genuity Initiates Coverage on priceline.com (PCLN) with a Buy; Secular and Cyclical Tailwinds; Margins Stable
-
UPDATE - Canaccord Genuity Initiates Coverage on Orbitz Worldwide (OWW) with a Hold; Playing International Catch-Up
-
UPDATE - Canaccord Genuity initiates coverage on OpenTable (OPEN) with a Buy; Large Addressable Market; New Revenue Opportunities
-
UPDATE - Canaccord Genuity Assuming Coverage on Netflix (NFLX) with a Buy; Best Consumer Option, Competition in Flux
-
UPDATE - Canaccord Genuity initiates coverage on Google (GOOG) with a Buy; Display Becoming Meaningful; Rapid Growth in Mobile
-
UPDATE - Canaccord Genuity Initiates Coverage on Expedia (EXPE) with a Hold; Balanced Risk/Reward
-
UPDATE - Canaccord Genuity initiates coverage on Ancestry.com (ACOM) with a Buy; Significant Market Opportunity
-
UPDATE - Canaccord Genuity Initiates Coverage on Amazon.com (AMZN) with a Buy; Significant Sustainable Competitive Advantages
-
Canaccord Genuity on Agriculture -- Fertilizer; Raises PT on MOS, POT & AGU
-
Canaccord Genuity Starts Orbitz Worldwide Inc. (OWW) at Hold
-
Canaccord Genuity Starts Expedia (EXPE) at Hold
-
Canaccord Genuity Starts Ancestry.com (ACOM) at Buy
-
Canaccord Genuity Starts Google (GOOG) at Buy
-
Canaccord Genuity Starts OpenTable (OPEN) at Buy
-
Canaccord Genuity Starts priceline.com (PCLN) at Buy
-
Canaccord Genuity Starts Amazon.com (AMZN) at Buy
-
Canaccord Genuity Starts Netflix (NFLX) at Buy
-
Notable Analyst Rating Changes 01/05: ADSK, NVDA, DIS, LL Upgraded; AA, DUK, CBEH, CNW Downgraded
-
Canaccord Genuity Starts Yahoo! (YHOO) at Hold
-
Canaccord Genuity Starts Shutterfly Inc. (SFLY) at Hold
-
Canaccord Genuity Starts eBay (EBAY) at Hold
-
Canaccord Genuity Starts Netflix (NFLX) at Buy
-
Analyst Round-Up: New Coverage on Motorola Mobility (MMI), Motorola Solutions (MSI)
-
Canaccord Genuity on Life Sciences/Biotechnology: Selected Small Cap Biotech Roundup
-
Canaccord Genuity Maintains a 'Speculative Buy' on Delcath Systems (DCTH); NDA Filing Sets Stage for 2011 Approval
-
Canaccord Genuity Reiterates a 'Hold' on Vertex (VRTX); Telaprevir + VX-222, IFN-free Combo Faces Another Challenge in All-Oral Quest
-
Canaccord Genuity Reiterates a 'Buy' on Cepheid (CPHD); Hospital Labs Look to Reduce MDx Send-Outs
-
Canaccord Genuity Moves Rating on Martek Biosciences (MATK) to Tender; DSM Sees the Value Shareholders Don't
-
Canaccord Genuity Reiterates a 'Hold' on Xilinx (XLNX); Slow Wireless Infrastructure Weighs on Outlook
-
Canaccord Genuity 2011 Technology Outlook
-
Canaccord Genuity: Sustainability -- Energy & Power Technologies
-
Canaccord Genuity Comm/Storage Analyst Rates NTAP, JNPR & CSCO) As 2011 Top Picks
-
Canaccord Genuity Maintains a 'Hold' on St. Jude Medical (STJ); FDA Approval of MDT's Arctic Front a Negative for STJ
-
Canaccord Genuity Reiterates a 'Buy' on Avanir Pharmaceuticals (AVNR); Management Dinner Takeaways: Nuedexta Launch, Commercial Strategy Shaping Up
-
Canaccord Genuity Reiterates a 'Buy' on Insulet Corporation (PODD); Capital Raise and Debt Extinguishment Completes Balance Sheet Makeover
-
Canaccord Genuity Reiterates a 'Buy' on InterMune (ITMN); Esbriet Could Be a Big Blockbuster in EU
-
Canaccord Genuity Maintains a 'Buy' on EnteroMedics (ETRM); Capital Raise Clears Way for US and OUS Commercialization Efforts
-
Canaccord Genuity Maintains a 'Speculative Buy' Æterna Zentaris (AEZS); Analyst and Investor Day: Highlighting a Deep Pipeline
